Gut 1999;45(Suppl 2):II37-II42 ( September )

Functional gastroduodenal disorders

N J Talley^a, V Stanghellini^b, R C Heading^c, K L Koch^d, J R Malagelada^e, G N J Tytgat^f

^a Chair, Committee on Functional Gastroduodenal Disorders, Multinational Working Teams to Develop Diagnostic Criteria for Functional Gastrointestinal Disorders (Rome II), Department of Medicine, University of Sydney, Penrith, Australia, ^b Co-Chair, Committee on Functional Gastroduodenal Disorders, Multinational Working Teams to Develop Diagnostic Criteria for Functional Gastrointestinal Disorders (Rome II), Department of Internal Medicine and Gastroenterology, Bologna, Italy, ^c University of Edinburgh, Edinburgh, Scotland, UK, ^d Milton S Hershey Medical Center, Hershey, PA, USA, ^e Digestive System Research Unit, Hospital General Vall D'Hebron, Barcelona, Spain, ^f Division of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands

Correspondence to: Nicholas J Talley, MD, Professor of Medicine, University of Sydney, Clinical Sciences Building, Nepean Hospital, PO Box 63, Penrith NSW 2751, Australia.

While widely used in research, the 1991 Rome criteria for the gastroduodenal disorders, especially symptom subgroups in dyspepsia, remain contentious. After a comprehensive literature search, a consensus-based approach was applied, supplemented by input from international experts who reviewed the report. Three functional gastroduodenal disorders are defined. Functional dyspepsia is persistent or recurrent pain or discomfort centered in the upper abdomen; evidence of organic disease likely to explain the symptoms is absent, including at upper endoscopy. Discomfort refers to a subjective, negative feeling that may be characterized by or associated with a number of non-painful symptoms including upper abdominal fullness, early satiety, bloating, or nausea. A dyspepsia subgroup classification is proposed for research purposes, based on the predominant (most bothersome) symptom: (a) ulcer-like dyspepsia when pain (from mild to severe) is the predominant symptom, and (b) dysmotility-like dyspepsia when discomfort (not pain) is the predominant symptom. This classification is supported by recent evidence suggesting that predominant symptoms, but not symptom clusters, identify subgroups with distinct underlying pathophysiological disturbances and responses to treatment. Aerophagia is an unusual complaint characterized by air swallowing that is objectively observed and troublesome repetitive belching. Functional vomiting refers to frequent episodes of recurrent vomiting that is not self-induced nor medication induced, and occurs in the absence of eating disorders, major psychiatric diseases, abnormalities in the gut or central nervous system, or metabolic diseases that can explain the symptom. The current classification requires careful validation but the criteria should be of value in future research.


Keywords: dyspepsia; functional dyspepsia; aerophagia; psychogenic vomiting; Rome II

---

© 1999 by Gut
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Talley, N. J (2008). Subdividing functional dyspepsia: a paradigm shift?. Gut 57: 1487-1489 [Full Text]  
• Bisschops, R, Karamanolis, G, Arts, J, Caenepeel, P, Verbeke, K, Janssens, J, Tack, J (2008). Relationship between symptoms and ingestion of a meal in functional dyspepsia. Gut 57: 1495-1503 [Abstract] [Full Text]  
• Banani, S. J., Lankarani, K. B., Taghavi, A., Bagheri, M. H., Sefidbakht, S., Geramizadeh, B. (2008). Comparison of metoclopramide oral tablets and solution in treatment of dysmotility-like dyspepsia. Am J Health Syst Pharm 65: 1057-1061 [Abstract] [Full Text]  
• Jiang, X, Locke, G R III, Choung, R S, Zinsmeister, A R, Schleck, C D, Talley, N J (2008). Prevalence and risk factors for abdominal bloating and visible distention: a population-based study. Gut 57: 756-763 [Abstract] [Full Text]  
• Talley, N J, Tack, J, Ptak, T, Gupta, R, Giguere, M (2008). Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Gut 57: 740-746 [Abstract] [Full Text]  
• Akamizu, T., Iwakura, H., Ariyasu, H., Hosoda, H., Murayama, T., Yokode, M., Teramukai, S., Seno, H., Chiba, T., Noma, S., Nakai, Y., Fukunaga, M., Nakai, Y., Kangawa, K., FD Clinical Study Team, (2008). Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite.. Eur J Endocrinol 158: 491-498 [Abstract] [Full Text]  
• Delaney, B. C, Qume, M., Moayyedi, P., Logan, R. F A, Ford, A. C, Elliott, C., McNulty, C., Wilson, S., Hobbs, F D R. (2008). Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial). BMJ 336: 651-654 [Abstract] [Full Text]  
• Lacy, B. E., Cash, B. D. (2008). A 32-Year-Old Woman With Chronic Abdominal Pain. JAMA 299: 555-565 [Abstract] [Full Text]  
• Rocca, G., Dioni, F., Rocca, N., Oliveri, F., Brunetto, M. R, Bonino, F. (2007). Thermal Care of Functional Dyspepsia Based on Bicarbonate-Sulphate-Calcium Water: A Sequential Clinical Trial. Evid Based Complement Alternat Med 4: 381-391 [Abstract] [Full Text]  
• Guilarte, M., Santos, J., de Torres, I., Alonso, C., Vicario, M., Ramos, L., Martinez, C., Casellas, F., Saperas, E., Malagelada, J. R. (2007). Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 56: 203-209 [Abstract] [Full Text]  
• Goetze, O., Steingoetter, A., Menne, D., van der Voort, I. R., Kwiatek, M. A., Boesiger, P., Weishaupt, D., Thumshirn, M., Fried, M., Schwizer, W. (2007). The effect of macronutrients on gastric volume responses and gastric emptying in humans: a magnetic resonance imaging study. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G11-G17 [Abstract] [Full Text]  
• Talley, N J, Locke, G R III, Lahr, B D, Zinsmeister, A R, Tougas, G, Ligozio, G, Rojavin, M A, Tack, J (2006). Functional dyspepsia, delayed gastric emptying, and impaired quality of life. Gut 55: 933-939 [Abstract] [Full Text]  
• Aro, P., Storskrubb, T., Ronkainen, J., Bolling-Sternevald, E., Engstrand, L., Vieth, M., Stolte, M., Talley, N. J., Agreus, L. (2006). Peptic Ulcer Disease in a General Adult Population: The Kalixanda Study: A Random Population-based Study. Am J Epidemiol 163: 1025-1034 [Abstract] [Full Text]  
• Moayyedi, P., Talley, N. J., Fennerty, M. B., Vakil, N. (2006). Can the Clinical History Distinguish Between Organic and Functional Dyspepsia?. JAMA 295: 1566-1576 [Abstract] [Full Text]  
• Gatta, L, Ricci, C, Tampieri, A, Osborn, J, Perna, F, Bernabucci, V, Vaira, D (2006). Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection: a randomised controlled trial. Gut 55: 457-462 [Abstract] [Full Text]  
• Simren, M, Stotzer, P-O (2006). Use and abuse of hydrogen breath tests. Gut 55: 297-303 [Abstract] [Full Text]  
• Bredenoord, A J, Weusten, B L A M, Smout, A J P M (2005). Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring. Gut 54: 1810-1817 [Full Text]  
• Bredenoord, A J, Weusten, B L A M, Sifrim, D, Timmer, R, Smout, A J P M (2004). Aerophagia, gastric, and supragastric belching: a study using intraluminal electrical impedance monitoring. Gut 53: 1561-1565 [Abstract] [Full Text]  
• Haag, S, Talley, N J, Holtmann, G (2004). Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters. Gut 53: 1445-1451 [Abstract] [Full Text]  
• Hammer, J, Eslick, G D, Howell, S C, Altiparmak, E, Talley, N J (2004). Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut 53: 666-672 [Abstract] [Full Text]  
• Locke, G. R. III, Murray, J. A., Zinsmeister, A. R., Melton, L. J. III, Talley, N. J. (2004). Celiac Disease Serology in Irritable Bowel Syndrome and Dyspepsia: A Population-Based Case-Control Study. Mayo Clin Proc. 79: 476-482 [Abstract]  
• Vakil, N. B, Vaira, D. (2003). Bugs, drugs, and dyspepsia in primary care. BMJ 327: E116-117 [Full Text]  
• Simren, M., Vos, R., Janssens, J., Tack, J. (2003). Acid infusion enhances duodenal mechanosensitivity in healthy subjects. Am. J. Physiol. Gastrointest. Liver Physiol. 285: G309-G315 [Abstract] [Full Text]  
• Jones, M. P., Hoffman, S., Shah, D., Patel, K., Ebert, C. C. (2003). The water load test: observations from healthy controls and patients with functional dyspepsia. Am. J. Physiol. Gastrointest. Liver Physiol. 284: G896-G904 [Abstract] [Full Text]  
• Jones, M P (2003). Evaluation and treatment of dyspepsia. Postgrad. Med. J. 79: 25-29 [Abstract] [Full Text]  
• Agreus, L (2002). Natural history of dyspepsia. Gut 50: iv2-9 [Abstract] [Full Text]  
• Tytgat, G N J (2002). Role of endoscopy and biopsy in the work up of dyspepsia. Gut 50: iv13-16 [Abstract] [Full Text]  
• Chiba, N., van Zanten, S. J O V., Sinclair, P., Ferguson, R. A, Escobedo, S., Grace, E. (2002). Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment---Helicobacter pylori positive (CADET-Hp) randomised controlled trial. BMJ 324: 1012-1012 [Abstract] [Full Text]  
• Vaira, D., Vakil, N., Menegatti, M., van't Hoff, B., Ricci, C., Gatta, L., Gasbarrini, G., Quina, M., Pajares Garcia, J. M., van der Ende, A., van der Hulst, R., Anti, M., Duarte, C., Gisbert, J. P., Miglioli, M., Tytgat, G. (2002). The Stool Antigen Test for Detection of Helicobacter pylori after Eradication Therapy. ANN INTERN MED 136: 280-287 [Abstract] [Full Text]  
• Collin, P., Rasmussen, M., Kyronpalo, S., Laippala, P., Kaukinen, K. (2002). The hunt for coeliac disease in primary care. QJM 95: 75-77 [Abstract] [Full Text]  
• Piessevaux, H, Tack, J, Wilmer, A, Coulie, B, Geubel, A, Janssens, J (2001). Perception of changes in wall tension of the proximal stomach in humans. Gut 49: 203-208 [Abstract] [Full Text]  
• Laine, L., Schoenfeld, P., Fennerty, M. B. (2001). Therapy for Helicobacter pylori in Patients with Nonulcer Dyspepsia: A Meta-Analysis of Randomized, Controlled Trials. ANN INTERN MED 134: 361-369 [Abstract] [Full Text]  
• Schwartz, M. D (2001). Review: prokinetics and histamine-2 receptor antagonists improve symptom scores in non-ulcer dyspepsia. Evid. Based Med. 6: 47-47 [Full Text]  
• van Zanten, S. J O V. (2001). Helicobacter pylori testing plus eradication was as effective and safe as prompt endoscopy for dyspepsia. Evid. Based Med. 6: 48-48 [Full Text]  
• Dent, J., Jones, R., Kahrilas, P., Talley, N. J (2001). Management of gastro-oesophageal reflux disease in general practice. BMJ 322: 344-347 [Full Text]